The financing was structured with a 65% loan-to-value (LTV) ratio, a 5-year loan term, and a 30-year amortization schedule ...
Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback